JaiRadhakrishnanMDMS

PubMed

• Kidney Dysfunction and Pathology in the Setting of Hemophagocytic Lymphohistiocytosis.
  Stokes, M., Jim, B., Marti, H., Eikrem, Ø., D'Agati, V., Markowitz, G., Sekulic, M., Batal, I., Kudose, S., Santoriello, D., Radhakrishnan, J.> ;Kidney International Reports. 2024 Feb 1
• Infection-Related Glomerulonephritis in Children and Adults.
  Arpana Iyengar, Nivedita Kamath, Jai Radhakrishnan, Blanca Tarragon Estebanez> ;Seminars in Nephrology. 2023 Sep 1
• Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
  Raina, R., Jothi, S., Haffner, D., Somers, M., Filler, G., Vasistha, P., Chakraborty, R., Shapiro, R., Randhawa, P., Parekh, R., Licht, C., Bunchman, T., Sethi, S., Ma...> ;Kidney International. 2024 Mar 1
• Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study.
  Maurer, M., Chakraborty, R., Mapara, M., Reshef, R., Radhakrishnan, J., Lentzsch, S., Bhutani, D.> ;American Journal of Hematology. 2024 Mar 1
• 1 citations
  International Variability in the Epidemiology, Management, and Outcomes of CKD and ESKD: A Systematic Review.
  Freedberg, D., Segall, L., Liu, B., Jacobson, J., Mohan, S., George, V., Kumar, R., Neugut, A., Radhakrishnan, J.> ;Kidney360. 2024 Jan 1
• 3 citations
  Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
  Yask Gupta, David J Friedman, Michelle T McNulty, Atlas Khan, Brandon Lane, Chen Wang, Juntao Ke, Gina Jin, Benjamin Wooden, Andrea L Knob, Tze Y Lim, Gerald B Appel, ...> ;Nature Communications. 2023 Nov 30
• 7 citations
  Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
  Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses A Diva, Jürgen Floege, Loreto Gesualdo, Jula K Inrig, Don...> ;Lancet. 2023 Dec 2
• 3 citations
  Challenges in IgA Nephropathy Management: An Era of Complement Inhibition.
  Vladimir Tesař, Jai Radhakrishnan, Vivek Charu, Jonathan Barratt> ;Kidney International Reports. 2023 Sep 1
• Implementation and Feasibility of Clinical Genome Sequencing Embedded Into the Outpatient Nephrology Care for Patients With Proteinuric Kidney Disease.
  Maddalena Marasa, Dina F Ahram, Atteeq U Rehman, Adele Mitrotti, Avinash Abhyankar, Namrata G Jain, Patricia L Weng, Stacy E Piva, Hilda E Fernandez, Natalie S Uy, Deb...> ;Kidney International Reports. 2023 Aug 1
• 15 citations
  Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
  Krzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, Francesca Zanoni, Lili Liu, Nikol Mladkova, Atlas Khan, Maddalena Marasa, Jun Y Zhang, Olivia Balderes, Simone...> ;Nature Genetics. 2023 Jul 1
• 3 citations
  Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
  Brendan R Emmons, Ibrahim Batal, Jai Radhakrishnan, S Ali Husain> ;Kidney International. 2023 Aug 1
• 2 citations
  Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review.
  Krzysztof Kiryluk, Daniel E Freedberg, Jai Radhakrishnan, Leslie Segall, Judith S Jacobson, Mohit Mathur, Sumit Mohan, Alfred I Neugut> ;Kidney360. 2023 Aug 1
• 11 citations
  IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study.
  Jonathan Barratt, Brad Rovin, Muh Geot Wong, Charles E Alpers, Stewart Bieler, Ping He, Jula Inrig, Radko Komers, Hiddo J L Heerspink, Alex Mercer, Irene L Noronha, Ja...> ;Kidney International Reports. 2023 May 1
• 2 citations
  The Difference Between Cystatin C- and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF.
  Alberto Pinsino, Matthew R Carey, Syed Husain, Sumit Mohan, Jai Radhakrishnan, Douglas L Jennings, Austin S Nguonly, Annamaria Ladanyi, Lorenzo Braghieri, Koji Takeda,...> ;American Journal of Kidney Diseases. 2023 Nov 1
• 35 citations
  Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
  Hiddo J L Heerspink, Jai Radhakrishnan, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Ulysses Diva, Jula Inrig, Radko Komers, Alex Mercer, Irene L Noronha, Miche...> ;Lancet. 2023 May 13
• Rare Single Nucleotide and Copy Number Variants and the Etiology of Congenital Obstructive Uropathy: Implications for Genetic Diagnosis.
  Dina F Ahram, Tze Y Lim, Juntao Ke, Gina Jin, Miguel Verbitsky, Monica Bodria, Byum Hee Kil, Debanjana Chatterjee, Stacy E Piva, Maddalena Marasa, Jun Y Zhang, Enrico ...> ;Journal of the American Society of Nephrology. 2023 Jun 1
• 6 citations
  First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy.
  Rajshekhar Chakraborty, Gurbakhash Kaur, Jai Radhakrishnan, Markus Y Mapara, Mathew Maurer, Suzanne Lentzsch, Rosenbaum, C., Bhutani, D.> ;British Journal of Haematology. 2023 Jun 1
• The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis.
  Benjamin Wooden, Jai Radhakrishnan> ;Clinical Journal of the American Society of Nephrology. 2022 Nov 1
• 1 citations
  International Physicians Delphi Survey: Managing Patients With IgA Nephropathy.
  Jürgen Floege, Jonathan Barratt, Rosanna Coppo, Richard Lafayette, Jai Radhakrishnan, Heather N Reich, Brad H Rovin, David T Selewski, Marina Vivarelli, Christopher Ph...> ;Kidney International Reports. 2022 Sep 1
• Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey.
  Jürgen Floege, Keisha L Gibson, Manuel Praga, Jai Radhakrishnan, Heather N Reich, Michiel F Schreuder, Jack F Wetzels, Vladimír Tesař, Marina Vivarelli, Steffen Bieche...> ;Kidney International Reports. 2022 Sep 1
• 4 citations
  Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis.
  Dawn J Caster, Barbara Magalhaes, Natali Pennese, Andrea Zaffalon, Marina Faiella, Kirk N Campbell, Jai Radhakrishnan, Vladmir Tesar, Howard Trachtman> ;Kidney Medicine. 2022 Aug 1
• Optimizing Perioperative Renal Replacement Therapy for Patients Undergoing Cardiac Surgical Procedures Requiring Cardiopulmonary Bypass.
  Jacob S Stevens, Jonathan M Hastie, Jessica Spellman, Aaron Mittel, James Beck, Dana A Mullin, Kenmond Fung, Michael Argenziano, Hiroo Takayama, Jai Radhakrishnan> ;Blood Purification. 2022 Jul 25
• 2 citations
  Strategies for Renal Protection in Cardiovascular Interventions.
  Ziad A Ali, Javier Escaned, Dariusz Dudek, Jai Radhakrishnan, Keyvan Karimi Galougahi> ;Korean Circulation Journal. 2022 Jul 1
• 1 citations
  Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis.
  Rajshekhar Chakraborty, Madeleine Hopson, George Vlad, Mathew S Maurer, Jan M Griffin, Markus Y Mapara, Jai Radhakrishnan, Suzanne Lentzsch, Bhutani, D.> ;American Journal of Hematology. 2022 Jul 1
• 5 citations
  Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-A...
  Kirk N Campbell, Natali Pennese, Andrea Zaffalon, Barbara Magalhaes, Marina Faiella, Dawn J Caster, Jai Radhakrishnan, Vladimir Tesar, Howard Trachtman> ;Kidney Medicine. 2022 May 1
• Join now to see all

Journal Articles

• DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS  
  Howard Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology
• Procurement Biopsies in the Evaluation of Deceased Donor Kidneys  
  Isaac E Hall, Sumit Mohan, Raphael Rosen, R John Crew, Geoffrey K Dube, Jai Radhakrishnan, David J Cohen, Journal of the American Society of Nephrology
• Glomerular Diseases Associated with Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation  
  Jhaveri KD, Shah HH, Patel C, Kadiyala A, Stokes MB, Radhakrishnan J., Adv Chronic Kidney Dis, 1/1/2014
• Taming the Chronic Kidney Disease Epidemic: A Global View of Surveillance Efforts  
  Radhakrishnan J, Remuzzi G, Saran R, et al, Kidney Int, 1/1/2014
• Kidneys at Higher Risk of Discard: Expanding the Role of Dual Kidney Transplantation  
  Tanriover B, Mohan S, Cohen DJ, Radhakrishnan J, Nickolas TL, Stone PW, Tsapepas DS, Crew RJ, Dube GK, Sandoval PR, Samstein B, Dogan E, Gaston RS, Tanriover JN, Ratne..., Am J Transplant., 1/1/2014
• Hemoglobinuric Acute Kidney Injury from Aortic Root Graft Malfunction  
  Mohan P, Block B, Reisinger N, Radhakrishnan J, Clin Nephrol, 1/1/2014
• The Treatment of Minimal Change Disease in Adults  
  Hogan J, Radhakrishnan J, J Am Soc Nephrol, 1/1/2013
• Prevalence of Hyponatremia and Association with Mortality: Results from NHANES  
  Mohan S, Gu S, Parikh A, Radhakrishnan J, Am J Med, 1/1/2013
• De Novo Membranous Nephropathy in Renal Allograft Associated with Antibody-mediated Rejection and Review of the Literature  
  Patel K, Hirsch J, Beck L, Herlitz L, Radhakrishnan J, Transplant Proc, 1/1/2013
• Venous Thromboembolism and Membranous Nephropathy: So What's New?  
  Radhakrishnan J, Clin J Am Soc Nephrol, 1/1/2012
• Echocardiographic Changes following Hemodialysis Initiation in Patients with Advanced Chronic Kidney Disease and Symptomatic Heart Failure with Reduced Ejection Fraction  
  Ganda A, Weiner SD, Chudasama NL, Valeri AM, Jadoon A, Shimbo D, Radhakrishnan J, Clin Nephrol, 1/1/2012
• Urinary Neutrophil Gelatinase-associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis  
  Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, Adkins SH, Sise ME, Oliver JA, Radhakrishnan J, Barasch JM, Nickolas TL, Dig Dis Sci, 1/1/2012
• Treatment of Nephrotic Syndrome with Adrenocorticotropic Hormone (ACTH) Discovery Medicine  
  Bomback A, Radhakrishnan J, Discov Med, 1/1/2011
• Therapy of Minimal Change Disease  
  Radhakrishnan J., 1/1/2011
• Treating Lupus in the Kidney: Where Are We Now, and Where Are We Going?  
  Canetta PA, Bomback AS, Radhakrishnan J, Discov Med, 1/1/2011
• Geographical Variation in the Response of Lupus Nephritis to Mycophenolate Mofetil Induction Therapy  
  Mohan S, Radhakrishnan J, Clin Nephrol, 1/1/2011
• Glomerular Disease: Why Is There a Dearth of High Quality Clinical Trials?  
  Leaf DE, Appel GB, Radhakrishnan J, Kidney Int, 1/1/2010
• Gastrointestinal Disorders and Renal Failure: Exploring the Connection  
  Shirazian S, Radhakrishnan J, Nat Rev Nephrol, 1/1/2010
• Do Meta-analyses in Nephrology Change the Way We Treat Patients?  
  Mohan S, Radhakrishnan J, Kidney Int, 1/1/2010
• Mycophenolate Mofetil and Intravenous Cyclophosphamide Are Similar as Induction Therapy for Class V Lupus Nephritis  
  Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB, Kidney Int, 1/1/2010
• Nonrenal Disease Activity following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis: Findings in a Multicenter, Prospe...  
  ALMS Group, Arthritis Rheum, 1/1/2010
• Pathologic Classification of Diabetic Nephropathy  
  Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, Heer ED, Joh K, Noël LH, Radhakrishnan J, Seshan SV, Bajema IM, Brui..., J Am Soc Nephrol., 1/1/2010
• Recurrent Focal Segmental Glomerulosclerosis in the Renal Allograft: Single Center Experience in the Era of Modern Immunosuppression  
  Schachter ME, Monahan M, Radhakrishnan J, Crew J, Pollak M, Ratner L, Valeri AM, Stokes MB, Appel GB, Clin Nephrol, 1/1/2010
• Case Records of the Massachusetts General Hospital Case 5-2010 A 51-year-old Man with HIV Infection, Proteinuria, and Edema  
  Radhakrishnan J, Uppot RN, Colvin RB, N Engl J Med, 1/1/2010
• Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis Aspreva Lupus Management Study Group  
  J Am Soc Nephrol, 1/1/2009
• Join now to see all

Books/Book Chapters

• Chronic Renal Disease 
  Chapter: Lupus Nephritis 
  Page 501.0 - 502.0Rovin B, Bomback A, Radhkrishnan JEditors: Kimmel PL & Rosenberg ME.Academic Press/Elsevier, San Diego2015
• Chronic Renal Disease 
  Chapter: Chronic Kidney Disease and Gastrointestinal Disorders 
  Page 298.0 - 309.0Lew SQ and Radhakrishnan J.Editors: Kimmel PL & Rosenberg ME.Academic Press/Elsevier, San Diego2015
• Core Concepts in Parenchymal Kidney Disease 
  Chapter: Minimal Change Disease in Adults 
  Page 15.0 - 21.0Hogan J, Radhakrishnan JEditors: Fervenza FC, Lin J, Sethi S, Singh AK.Springer, New York2014
• National Kidney Foundation’s Primer on Kidney Diseases 
  Chapter: Minimal Change Disease 
  Page 170.0 - 175.0Trachtman H, Hogan J, Radhakrishnan JEditors: Gilbert S, Weiner DE.Elsevier, PhiladelphiaEdition 6.0,2014
• Brenner & Rector's the Kidney 
  Chapter: Secondary Glomerular Disease 
  Page 1067. - 1126.Appel GB, Radhakrishnan J, D'Agati VEditors: Brenner BM.Saunders, PhiladelphiaEdition 8.0,2008
• Contributions to Nephrology 
  Chapter: The Use of Cyclosporine in Lupus Nephritis 
  Page 59.0 - 72.0Radhakrishnan J, Appel GB1995
• Join now to see all

Lectures

• Renal Biopsy in Medical Diseases of the Kidneys 
  Columbia University, New York, New York - 7/1/2020
• Annual Update & Intensive Review of Internal Medicine Board Review 2013 
  Columbia University Medical Center, Burlington, Massachusetts - 6/2/2020

Other

• Renal disease in Sjogren's syndrome 
  Radhakrishnan J, UpToDate, Wolters Kluwer Health
  http://www.uptodate.com/contents/renal-disease-in-sjogrens-syndrome
  UpToDate, Wolters Kluwer Health - 2013-03-26
• Staphylococcus-associated Glomerulonephritis in Adults 
  Nasr SH, Radhakrishnan J, D'Agati VD, UpToDate
  1/1/2013
• Renal Vein Thrombosis and Hypercoagulability in Nephrotic Syndrome 
  Radhakrishnan J, UpToDate
  1/1/2010
• Hyperlipidemia in Nephrotic Syndrome 
  Radhakrishnan J, UpToDate
  1/1/2010
• Lipid abnormalities in nephrotic syndrome 
  Radhakrishnan J, Appel GB
  http://www.uptodate.com/contents/lipid-abnormalities-in-nephrotic-syndrome
  UpToDate, Wolters Kluwer Health - 2012-06-06
• Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt 
  Radhakrishnan J
  http://www.uptodate.com/contents/renal-disease-in-the-setting-of-infective-endocarditis-or-an-infect
  UpToDate, Wolters Kluwer Health - 2013-01-24
• Endocrine dysfunction in the nephrotic syndrome 
  Radhakrishnan J
  http://www.uptodate.com/contents/endocrine-dysfunction-in-the-nephrotic-syndrome
  UpToDate, Wolters Kluwer Health - 2013-01-24
• Diagnosis and treatment of renal infarction 
  Radhakrishnan J
  http://www.uptodate.com/contents/diagnosis-and-treatment-of-renal-infarction
  UpToDate, Wolters Kluwer Health - 2013-04-12
• Renal vein thrombosis and hypercoagulable state in nephrotic syndrome 
  Radhakrishnan J
  http://www.uptodate.com/contents/renal-vein-thrombosis-and-hypercoagulable-state-in-nephrotic-syndro
  UpToDate, Wolters Kluwer Health - 2012-02-03
• Pathophysiology and treatment of edema in patients with the nephrotic syndrome 
  Radhakrishnan J
  http://www.uptodate.com/contents/pathophysiology-and-treatment-of-edema-in-patients-with-the-nephrot
  UpToDate, Wolters Kluwer Health - 2012-02-29
• Join now to see all